HMGB1 and diabetic cardiomyopathy: Similarly, by modulating the AGE–RAGE/HMGB-1 signaling pathway, which affects oxidative stress, inflammation, and fibrosis, artemisinin has been shown to contribute to the amelioration of diabetic cardiomyopathy [48].